Milind Deshpande

2016

In 2016, Milind Deshpande earned a total compensation of $3M as Director, President and Chief Executive Officer at Achillion Pharmaceuticals, a 213% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$218,144
Option Awards$2,153,727
Salary$590,000
Other$8,310
Total$2,970,181

Deshpande received $2.2M in option awards, accounting for 73% of the total pay in 2016.

Deshpande also received $218.1K in non-equity incentive plan, $590K in salary and $8.3K in other compensation.

Rankings

In 2016, Milind Deshpande's compensation ranked 3,231st out of 14,075 executives tracked by ExecPay. In other words, Deshpande earned more than 77.0% of executives.

ClassificationRankingPercentile
All
3,231
out of 14,075
77th
Division
Manufacturing
1,118
out of 5,486
80th
Major group
Chemicals And Allied Products
329
out of 1,900
83rd
Industry group
Drugs
238
out of 1,543
85th
Industry
Pharmaceutical Preparations
185
out of 1,173
84th
Source: SEC filing on April 17, 2017.

Deshpande's colleagues

We found four more compensation records of executives who worked with Milind Deshpande at Achillion Pharmaceuticals in 2016.

2016

Joel Barrish

Achillion Pharmaceuticals

Chief Scientific Officer

2016

David Apelian

Achillion Pharmaceuticals

Chief Medical Officer

2016

Joseph Truitt

Achillion Pharmaceuticals

Executive Vice President and Chief Commercial Officer

2016

Mary Fenton

Achillion Pharmaceuticals

Chief Financial Officer

News

In-depth

You may also like